Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients


Autoria(s): Aikawa, N. E.; Jesus, A. A.; Liphaus, B. L.; Silva, C. A.; Carneiro-Sampaio, M.; Viana, V. S. T.; Sallum, A. M. E.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Objectives To our knowledge, no study assessed simultaneously a variety of organ-specific autoantibodies and the prevalence of organ-specific autoimmune diseases in juvenile systemic lupus erythematosus (ISLE) and juvenile dermatomyositis (JDM). Therefore, the purpose of this study was to evaluate organ-specific autoantibodies and autoimmune diseases in JSLE and JDM patients. Methods Forty-one JSLE and 41 JDM patients were investigated for autoantibodies associated with autoimmune hepatitis, primary biliary cirrhosis, type I diabetes mellitus (TIDM, autoimmune thyroiditis (AT), autoimmune gastritis and coeliac disease (CD). Patients with positive antibodies were investigated for the respective organ-specific autoimmune diseases. Results Mean age at diagnosis was higher in ISLE compared to JDM patients (10.3 +/- 3.4 vs. 7.3 +/- 3.1 years, p=0.0001). The frequencies of organ-specific autoantibodies were similar in JSLE and JDM patients (p>0.05). Of note, a high prevalence of TIDM and AT autoantibodies was observed in both groups (20% vs. 15%, p=0.77 and 24% vs. 15%, p=0.41; respectively). Higher frequencies of ANA (93% vs. 59%, p=0.0006), anti-dsDNA (61% vs. 2%, p<0.0001), anti-Ro, anti-Sm, anti-RNP, anti-La and IgG-aCL were observed in JSLE (p<0.05). Organ-specific autoimmune diseases were evidenced only in ISLE patients (24% vs. 0%, p=0.13). Two ISLE patients had TIDM associated with Hashimoto thyroiditis and another had subclinical thyroiditis. Another JSLE patient had CD diagnosis based on iron deficiency anaemia, anti-endomysial antibody, duodenal biopsy compatible to CD and response to a gluten-free diet. Conclusions Organ-specific diseases were observed solely in ISLE patients and required specific therapy. The presence of these antibodies recommends the evaluation of organ-specific diseases and a rigorous follow-up.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [08/58238-4]

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [300248/2008-3]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Federico Foundation

Federico Foundation

Identificador

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, PISA, v. 30, n. 1, supl., Part 1-2, pp. 126-131, JAN-FEB, 2012

0392-856X

http://www.producao.usp.br/handle/BDPI/41379

10.1186/1546-0096-10-S1-A14

http://dx.doi.org/10.1186/1546-0096-10-S1-A14

Idioma(s)

eng

Publicador

CLINICAL & EXPER RHEUMATOLOGY

PISA

Relação

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Direitos

restrictedAccess

Copyright CLINICAL & EXPER RHEUMATOLOGY

Palavras-Chave #ORGAN-SPECIFIC #AUTOANTIBODIES #JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS #JUVENILE DERMATOMYOSITIS #RHEUMATOLOGY
Tipo

article

original article

publishedVersion